AZZA3

Azzas 2154 S.A. (AZZA3)

Azzas 2154 is Latin America's largest fashion group, born in August 2024 from the merger of Arezzo&Co and Grupo Soma. It gathers more than 20 brands across four verticals — shoes and handbags (Arezzo, Schutz, Anacapri, Alexandre Birman, Vans), women's fashion (FARM Rio, Animale, NV, Maria Filó), men's fashion (Reserva, Oficina, Foxton) and basics (Hering) — with net revenue of R$ 11.8 billion in 2025, an omnichannel operation and a growing international footprint through FARM Rio.

Sector: Textiles & Apparel · Share price: R$ 17.48 (close on Jul 21, 2026) · Dividend yield (12m): 14.17% · 52-week range: R$ 16.10 – 38.49

Full analysis of AZZA3 (produced by this site with AI, Jul 21, 2026)

Rating: 6.0/10 · Verdict: UNDER REVIEW · Estimated fair price: R$ 26.00 (range R$ 16.00–34.00)

AZZA3 is the largest fashion group in Latin America — Arezzo, Schutz, FARM Rio, Animale, Reserva and Hering under one roof, with R$ 11.8 bn in revenue and R$ 770.7 mn in recurring net income in 2025. The stock, however, has fallen ~55% since the 2024 merger and trades at 0.46x book value and ~5x recurring earnings, with a dividend yield of 13.6% over the trailing 12 months.

The discount has two concrete causes: the shareholder war between founders Alexandre Birman and Roberto Jatahy — which ended up in court and in CAM-B3 arbitration in May 2026, with a truce stitched together in June — and the operational deterioration of 2026: in Q1, revenue fell 8%, recurring EBITDA fell 23% and recurring net income plunged 45.7%, with Hering still weighing on margins and guidance officially withdrawn. Rating 6.0/10 — UNDER REVIEW: fair price estimated at R$ 26.00 (upside of +43%), but the thesis hinges on two tests — the shareholder peace proving durable and second-half 2026 results showing revenue and margin stabilization.

Overview

Azzas owns the brands you see at the mall: Arezzo, Schutz, FARM, Animale, Reserva and Hering. In 2024, the two largest publicly traded fashion companies (Arezzo&Co and Grupo Soma) merged to create this giant. On paper, it made total sense: more scale, lower costs, strong brands together.

In practice, it turned into a soap opera. The two founders — Alexandre Birman (Arezzo) and Roberto Jatahy (Soma) — couldn't agree on who's in charge of what, and the fight ended up in court in May 2026. On top of that, middle-class consumers squeezed by high interest rates bought less, Hering (the group's most popular brand) is undergoing a deep overhaul, and early-2026 profit came in at nearly half the prior year's level. The result: the stock fell from ~R$ 49 (its merger debut) to ~R$ 18.

The other side of the coin: at the current price, the market pays less than half of book value for a group that earned R$ 770 million in profit in 2025 and paid out fat dividends (13.6% return over 12 months). If the peace between the partners holds and sales stop falling, there's a lot of value here. If the fight comes back, cheap can stay cheap. The upcoming results (August and November 2026) and the arbitration between the partners are the judges.

Investment thesis

The AZZA3 thesis is deep value with a shareholder catalyst, built on three pillars: (i) rare-quality assets — a portfolio of leading brands with 55% gross margin, national reach and one brand (FARM Rio) in genuine global expansion; (ii) maximum-pessimism pricing — 0.46x book value, ~5x recurring earnings and EV/EBITDA ~3x, multiples of a company in crisis for a group that is profitable and pays dividends (13.6% yield over 12 months); (iii) mappable catalysts — a shareholder truce with a new shareholders' agreement (Jun/2026), a reshuffled board, a possible spin-off or asset sale (a group linked to Hering's founding family (a stake reported by the press, not visible in the FRE) has already hired a bank to try to buy back the brand — JP Morgan estimates the Hering operation at R$ 600-800 mn) and the interest rate cycle turning in favor of consumption.

The counterweight: broken governance at the top is exactly the kind of risk that destroys a value thesis — while Birman and Jatahy fight for power in arbitration, strategic decisions are held hostage; the operation is deteriorating (Q1 2026 weak across the board), guidance was withdrawn, and 8+ senior executives left in 18 months. The stock is cheap on the STOCK of value (brands, book value, past earnings), but the FLOW (revenue and margin trend) points downward. Whoever buys in today needs the stomach for headline volatility and the patience for 2-3 years — buying the discount before the proof that the house has been put in order.

Strengths

  • Leading, diversified brand portfolio. More than 20 brands spanning from luxury (Alexandre Birman) to basics (Hering), with #1 or #2 positions in their niches. A 55% gross margin proves pricing power — very few Brazilian retailers have that.
  • Extreme book-value discount. P/BV of 0.46x: the market pays R$ 3.7 bn for a group with R$ 8.0 bn in equity, R$ 11.8 bn in revenue and R$ 770 mn in recurring net income in 2025 (~5x earnings). A broken-company multiple for a profitable company.
  • Fat shareholder distributions. R$ 667 mn returned in 2025 (R$ 500 mn in dividends + R$ 167 mn in buybacks) — a 13.6% yield over 12 months. The buyback remains active, purchasing the stock below 0.5x book value.
  • FARM Rio: global engine. The group's most valuable brand is growing abroad (US, Europe, Dubai, Mexico, Argentina) through asset-light partners — a real growth avenue that doesn't depend on domestic consumption.
  • Leverage still manageable. Net debt/EBITDA of 1.40x with R$ 1.06 bn in cash, a lengthened maturity profile (67% of debt long-term after 2025 debenture issuances) and R$ 1.27 bn in credit-card receivables as extra liquidity.
  • Capital discipline underway. Capex cut 31%, 6 loss-making brands discontinued (their revenue fell 84%), operating cycle 13 days shorter and ROIC declared the 2026 priority — the house-cleaning has begun.

Weaknesses

  • Governance at war. The two founding controlling shareholders have been fighting for power in CAM-B3 arbitration since May/2026. Birman unilaterally reversed an approved integration, Jatahy went to court. The June truce (new shareholders' agreement, reshuffled board) is recent and untested.
  • Operation deteriorating. Q1 2026: revenue -8%, recurring EBITDA -23.2%, recurring net income -45.7%, EBITDA margin -2.7 p.p. The decline is broad-based and predates the worst of the shareholder crisis — you can't blame the fight alone.
  • Hering: margin anchor. The Basic vertical drags the group's margin down by ~2 p.p. (16.4% vs. 18.4% ex-Hering) and has been in a 'deep transformation' since Oct/2025 — turning around a mass-market brand during a weak consumption cycle is a risky bet.
  • Executive exodus. 8+ senior leaders left in ~18 months: Rony Meisler (Reserva's founder), Thiago Hering, Ruy Kameyama, the COO, the CHRO, the CMO and two CFOs. Citi cited the turnover as a central risk. A brand company depends on its people.
  • Guidance withdrawn. A material fact on March 11, 2026 discontinued all projections. With no public synergy target (there was never an official number) and no margin guidance, the investor navigates without instruments.
  • Merger synergies unproven. The merger was sold as value creation through scale; 2 years later, the stock is down ~55%, the vertical-integration project (estimated synergy of R$ 80-116 mn in EBITDA) was reversed in the middle of the fight, and no capture was ever quantified to the market.

Risks

  • The shareholder war reigniting. It's risk #1. CAM-B3 arbitration remains open and the truce is only weeks old. A new chapter (an unfavorable ruling, a broken agreement, Jatahy leaving and taking talent from the women's brands with him) would once again paralyze strategy and hit the stock. In the extreme, a DISORDERLY spin-off — splitting systems, logistics and teams in the middle of a turnaround — would destroy value instead of unlocking it.
  • Q1 2026 becoming a trend, not an accident. If revenue and margin keep falling in H2 2026, recurring net income of R$ 770 mn turns into R$ 500-550 mn, the 'cheap' 5x P/E becomes 7x without the stock rising, and dividends shrink along with it. The value thesis needs the deterioration to STOP — and discretionary consumption under still-high Selic doesn't help.
  • Hering turnaround failing. Hering was bought by Soma for R$ 5.5 bn in 2021, and today the entire group is worth R$ 3.8 bn on the stock exchange. The transformation started in Oct/2025 competes with press-reported interest from a group linked to the Hering family in buying back the brand. Selling cheap would crystallize value destruction; not selling and not turning it around prolongs the ~2 p.p. margin bleed.
  • Weak consumption for longer. Fashion is the first thing cut from the family budget. With high real interest rates, record household debt and an election year, the sector projects 'modest' growth for 2026. The premium segment (Arezzo, FARM) holds up better, but Hering and franchises suffer — and they are half the story.
  • Competition from imports and taxation. Loosening the taxation of small parcel imports (Shein/Shopee) would pressure exactly the Hering segment. The tax reform transition adds margin uncertainty for all of retail through 2027+.
  • Leverage rising in a bad cycle. 1.40x net debt/EBITDA is still comfortable, but the direction is uncomfortable: stable debt with falling EBITDA. If recurring EBITDA drops to ~R$ 1.5 bn and the company keeps fat dividends, the metric goes to ~1.8x — nothing explosive, but it reduces the room to buy back shares and invest in Hering at the same time.

Scenarios

Otimista: Peace, Hering turnaround and re-rating

Recurring net income normalizes at R$ 900-1,000 mn (2027) and the market accepts paying 7-8x earnings for a pacified group — equity value of R$ 6.5-8 bn. This is the scenario behind Itaú BBA's (R$ 36) and XP's (R$ 40) price targets. Indicative price: R$ 36.00.

Base: Truce holds, operation stabilizes

The stock exits panic mode but without an upside catalyst: it re-rates to ~0.65-0.70x book value (~6-7x earnings) while the market waits for proof of the turnaround. Returns come from dividends plus a partial narrowing of the discount. Indicative price: R$ 26.00.

Pessimista: The fight returns and consumption doesn't help

Another year of falling profit alongside shareholder headlines. The book-value discount stops being a floor (merger goodwill under impairment) and the stock heads toward 0.35-0.40x P/BV. Yield shrinks and the income investor holding the stock sells. Indicative price: R$ 14.00.

Valuation

AZZA3 trades at the multiples of a company in terminal crisis — recurring P/E ~5x, EV/EBITDA ~3.2x, P/BV 0.47x — while being a profitable, market-leading, dividend-paying company. The discount isn't free: it prices in the shareholder war, the 2026 deterioration and post-merger distrust. Our approach cross-checks three methods on RECURRING earnings (never the reported figure inflated by deferred tax credit) and converges on a range of R$ 23 to R$ 29, with a central point of R$ 26.00 — an upside of +43% over R$ 18.21. For reference, sell-side consensus (13 analysts) sits at R$ 34.81, with Itaú BBA at R$ 36 (buy), XP at R$ 40 (buy), Citi at R$ 28 (neutral, downgraded in Jan/2026) and Safra at R$ 26 (neutral). Our number sits deliberately below consensus: sell-side targets assume a stabilization that the Q1 2026 data has not yet shown.

  • P/E on normalized earnings: R$ 26.00 — Mid-cycle recurring net income of ~R$ 720 mn (between the 2025 result and the weak 2026 pace) × a 7.5x P/E — a multiple penalized versus premium retail (Vivara 15x+) for governance risk. Equity of ~R$ 5.4 bn ÷ ~202 mn shares (ex-treasury; total of 206.5 mn).
  • Normalized EV/EBITDA: R$ 25.00 — Normalized recurring EBITDA of ~R$ 1.85 bn × 4x (vs. ~3.2x currently; healthy peers trade at 6-8x) = EV of R$ 7.4 bn, minus net debt of R$ 2.2 bn = equity of ~R$ 5.2 bn.
  • P/BV × profitability: R$ 25.50 — Book value of R$ 39.60/share with a recurring ROE of ~9% (below the cost of capital) justifies a P/BV of 0.60-0.70x until ROE proves sustainable above 12%. Merger goodwill embedded in equity calls for an additional discount.
  • Reference: sell-side consensus: R$ 34.80 — Median of 13 analysts (Investing.com, Jul/2026): R$ 34.81. Itaú BBA R$ 36 and XP R$ 40 (buy); Citi R$ 28 and Safra R$ 26 (neutral). Used only as a sanity check — not included in the average.

Timing

Where we are in the cycle: at the bottom of pessimism — the stock is hovering around its post-merger historical low (R$ 16.10) and trades below the sell-side's most conservative target. Two clocks are running at once: the shareholder clock (the June truce needs to survive the next chapters of arbitration) and the operational clock (Q2 2026, in August, will tell whether the Q1 2026 tumble was an accident or a trend). The asymmetry is inviting — +43% to our fair price, dividends along the way, and three mapped catalysts (durable peace, the Hering turnaround, a possible spin-off/sale unlocking value) — but buying before both clocks strike is accepting headline volatility. For those wanting a middle ground: a small position now, adding only on an objective signal — revenue stabilizing in Q2 2026 and no shareholder rupture for two straight quarters.

Management — who runs the company

Management rating: 4.5/10

This is the weak point of the thesis — and the central reason for the discount. Azzas has two owners used to being in charge alone: Alexandre Birman (CEO, family holding ~21% of capital) and Roberto Jatahy (Chief Brand Officer, ~10% with his sisters). The power-sharing arrangement designed in the merger collapsed in 2026: Birman reversed, via material fact, a board-approved vertical integration, Jatahy responded with an injunction and a lawsuit for breach of fiduciary duty, and the dispute ended up in CAM-B3 arbitration (May/2026). The June truce — a redesigned shareholders' agreement and a board elected at the April 2026 general meeting, chaired by Sylvia Leão Wanderley (with BOTH Birman and Jatahy sitting on the board itself and only 2 formal independents among 9 members) — is a real step forward, but it's only weeks old.

Add to that chronic turnover (8+ senior executives in 18 months, including two CFOs, the founder of Reserva and the CEO of the Basic vertical) and the guidance withdrawal, and the picture is one of management that's competent on brands but dysfunctional at the top. On the positive side: CFO Eric Alencar (since Sep/2025) has brought visible capital discipline (capex -31%, operating cycle -13 days, trimmed portfolio), the stated ROIC priority for 2026 is the right agenda, and the arrival of heavyweight board members signals a serious attempt at professionalization. Rating 4.5/10: Azzas's problem isn't capability — it's the cap table fighting under its own roof.

  • Alexandre Café Birman — Chief Executive Officer (CEO) · co-founder and controlling shareholder. Son of Arezzo's founder, he built Schutz and the international footwear operation. Controls ~21% of the capital with his family. A centralizer — the unilateral decision to reverse the vertical integration in Apr/2026 set off the shareholder crisis. He is simultaneously the group's biggest commercial asset and the source of its biggest governance risk.
  • Roberto Jatahy — Chief Brand Officer (women's and men's fashion) · co-founder. Creator of Grupo Soma (Animale, FARM Rio, NV). Holds ~10% of the capital with his sisters. A consensus-building style, the opposite of Birman's. He initiated the May/2026 judicial/arbitration dispute to preserve his scope of command — his role is, literally, the subject of the ongoing arbitration.
  • Eric Alexandre Alencar — Chief Financial and Investor Relations Officer (CFO/IRO). The group's third CFO in two years — and, so far, good news: capex cut 31%, debt lengthened via debentures, operating cycle 13 days shorter and a stated ROIC agenda. He inherited the mission of proving the conglomerate generates enough cash for dividends, buybacks and the Hering turnaround at the same time.
  • Sylvia de Souza Leão Wanderley — Chair of the Board of Directors. Chairs the 9-member board elected at the April 2026 general meeting — a seat that changed hands three times in ~12 months (Parente and Calicchio both held it; Calicchio remains a sitting board member, alongside names like Mauro Cunha and Lucas Fox, the 2 formal independents). Mission: arbitrate the coexistence of the two founding controlling shareholders within the board itself.
  • Gustavo Fonseca — Head of Hering's transformation (Basic vertical). An 11-year veteran of the company, he took over Hering after Thiago Hering's departure. He runs the turnaround of the brand that costs the group ~2 p.p. of margin — and that a group linked to the Hering family is reportedly trying to buy back, according to the press. It's the company's hottest operating seat.

Delivered: corporate integration completed without operational disruption; 55% gross margin preserved; R$ 667 mn returned to shareholders in 2025; real capital discipline (capex -31%, 6 loss-making brands cut, debt lengthened); FARM Rio growing internationally.

What fell short: the merger's central promise — synergies — was never quantified to the market, and the integration project was reversed in the middle of the fight; the stock has fallen ~55% since its debut; guidance was withdrawn (Mar/2026); 8+ senior executives left; and governance at the top became an arbitration case. The test for the current setup: whether the Jun/2026 truce survives the weak 2026 results and the arbitration ends without rupture.

Governance, control and liquidity

On paper, the structure is good: Novo Mercado (100% common shares, tag-along rights), Deloitte as auditor, and heavyweight institutional investors in the free float (Westwood 9.5%, BlackRock 6.1%, Fidelity 5.0%). In practice, 2026 showed that a shareholders' agreement is only worth as much as the partners want to honor it: the Birman × Jatahy dispute went through a material fact, an injunction, a lawsuit and arbitration (CAM-B3) before the June truce. The control block gathers 11 signatories holding 34.4% of the capital — the Birman family ~21.2% and the Jatahy family ~10.3% — and the 9-member board, chaired by Sylvia Leão Wanderley, has BOTH founders sitting on it and only 2 formal independents: a weak counterweight for a cap table in conflict. The group linked to Hering's founding family, which the press reports is trying to buy back the brand via BR Partners, does not show up with a relevant position in the FRE — the company responded that Hering 'is not for sale at this time.' With ~R$ 49 mn/day in liquidity, the stock is liquid enough for large positions — and for the headline volatility this saga produces.

  • Control: Shareholders' agreement: 34.4% (Birman ~21.2% + Jatahy ~10.3%)
  • Free float: ~63.5% (Westwood 9.5% · BlackRock 6.1% · Fidelity 5.0%)
  • Average daily liquidity: ~R$ 49 mn/day
  • Listing: Novo Mercado (B3) · 206.5 mn common shares
  • Buyback: R$ 167 mn in 2025 · 2.1% in treasury
  • Audit: Deloitte

Conclusion

Azzas 2154 is a rare case of excellent assets inside a broken shareholder structure. The brands are leaders, the 55% gross margin is big-league, the group earned R$ 770 mn in recurring profit in 2025 and returned R$ 667 mn to shareholders. But the merger that created the giant also created a condominium of two owners who don't get along — and 2026 laid that bare with lawsuits, arbitration and the operation deteriorating alongside it (revenue -8%, recurring net income -45.7% in Q1 2026).
At R$ 18.21 (0.46x book value, ~5x earnings), the market already pays VERY little for the whole package — our valuation points to a fair price of R$ 26.00 (range R$ 16-34), and even the sell-side's most conservative targets sit above the screen price. The discount, however, doesn't close on its own: it needs durable shareholder peace AND operational stabilization in the second half of 2026. These are two observable events, with dates (August and November results; arbitration chapters) — the investor doesn't need to guess, they need to watch.
In one sentence: a value thesis with a shareholder catalyst, for a small position, a strong stomach and active monitoring. Whoever buys in today is buying maximum pessimism with dividends paying for the wait; whoever prefers safety can wait for Q2 2026 and the consolidation of the truce — probably paying 20-30% more in exchange for much less headline risk.

Analysis produced by Rico aos Poucos with AI assistance, based on public filings (CVM), market data and news. Not investment advice.

Company details (CVM registry)

  • CNPJ (tax ID): 16.590.234/0001-76
  • CVM code: 22349
  • Sector: Textiles & Apparel
  • CVM category: Category A
  • Headquarters: BELO HORIZONTE / MG
  • Investor Relations Officer: Eric Alexandre Alencar
  • Auditor: DELOITTE TOUCHE TOHMATSU AUDITORES INDEPENDENTES LTDA.
  • CVM registration: Jan 31, 2011
  • Status: ACTIVE

Dividends by year

  • 2025: R$ 2.4762 across 2 payment(s)
  • 2024: R$ 1.1159 across 2 payment(s)
  • 2023: R$ 1.9325 across 2 payment(s)
  • 2022: R$ 1.8356 across 3 payment(s)
  • 2021: R$ 0.9270 across 3 payment(s)
  • 2020: R$ 0.5307 across 1 payment(s)
  • 2019: R$ 1.4108 across 5 payment(s)
  • 2018: R$ 1.2848 across 5 payment(s)
  • 2017: R$ 2.0590 across 4 payment(s)
  • 2016: R$ 0.3772 across 2 payment(s)

Recent filings (CVM)

Data content (price, dividends and filings) plus in-house AI-assisted analysis; not investment advice. Sources: B3/Yahoo Finance and CVM (Brazilian SEC).